Intraosseous Devices Market

How big is the Intraosseous Devices Market in 2026?

USD 523.0 million in 2026, reaching USD 919.0 million by 2036 at a 5.8% CAGR

The intraosseous devices market was valued at USD 494.3 million in 2025. The market is set to reach USD 523.0 million by 2026-end and grow at a CAGR of 5.8% between 2026-2036 to reach USD 919.0 million by 2036. Powered Drill will dominate with a 42.0% share, while Distal And Proximal Tibia will lead with a 44.0% share.

Emergency vascular access remains a persistent clinical pressure point in trauma care and pre-hospital medicine. Intraosseous devices address peripheral IV failure during cardiac arrest, hemorrhagic shock, and mass casualty events. Demand is shaped by emergency department caseloads, first-responder procurement cycles, and hospital training protocols.

Growth reflects the integration of powered drill IO systems into emergency medicine training across North America and Western Europe. The American Heart Association confirmed intraosseous access as a recommended route in its 2025 ACLS guidelines. That endorsement is expected to raise procurement for hospitals replacing aging manual insertion devices with powered alternatives.

Key Takeaways

• Emergency department caseloads and pre-hospital trauma protocols are expected to sustain device procurement across hospitals and EMS agencies.
• Powered Drill is expected to account for 42.0% of technology demand in 2026 due to faster insertion and higher first-attempt success rates.
• Distal And Proximal Tibia is projected to hold 44.0% of route of administration demand in 2026 because tibial sites offer accessible landmarks in emergency settings.
• Hospitals are anticipated to represent 72.0% of end-user demand in 2026, supported by emergency department standardization and equipment replacement cycles.
• India leads with a 5.8% CAGR through 2036 as tertiary care expansion and emergency medicine formalization raise procurement volumes.
• Teleflex and BD are expected to compete through broad vascular access portfolios and established hospital procurement relationships.

Analyst Perspective

"Buyers are expected to judge powered drill on performance and total cost of ownership rather than headline price. Intraosseous device adoption is expected to depend on evidence that powered drill systems reduce insertion failure across emergency and critical care settings. Suppliers that link first-attempt success data with operator training and multi-site compatibility are likely to secure stronger renewal discussions. Market success is projected to depend on translating clinical guideline endorsements into repeatable procurement cycles across hospital and pre-hospital buyer groups."
- Anurag Sharma, Principal Consultant at Future Market Insights

Why is the Intraosseous Devices Market growing?

Rising Powered Drill and Distal And Proximal Tibia demand across healthcare end users

• Powered intraosseous access is procured on emergency-protocol replacement and expanding EMS and military channels, not on new-facility construction.
• India leads growth at 5.8% CAGR as tertiary care expansion and emergency medicine formalization raise procurement volumes.
• Distal And Proximal Tibia holds 44.0% of route of administration revenue, indicating where standardization is concentrating buyer spend.

Because resuscitation guidelines anchor device choice, intraosseous device spend stays with vendors whose powered drills are already referenced in AHA and ERC protocols and backed by field-proven service.

How is the intraosseous devices market segmented?

The intraosseous devices industry is segmented by technology, route of administration, end user, patient type, application, and region.

The intraosseous devices market is segmented by technology, route of administration, end user, patient type, application, and region. By technology, the market covers powered drill, manual, automatic, and impact driven devices. By route of administration, the market covers distal and proximal tibia, sternum, distal femur, calcaneus, and head of humerus. By end user, the market covers hospitals, ambulatory surgical centers, and cardiology clinics. By patient type, the market covers adult, pediatric, and geriatric patients. By application, the market covers emergency medicine, military and disaster medicine, and critical care and surgery. Regions include North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa.

How does powered drill technology shape demand within the technology category?

Technology choice determines insertion speed and first-attempt success in time-critical emergencies. Powered drill devices reduce operator dependency compared to manual alternatives. The American Heart Association reaffirmed IO access as a recommended vascular route in its 2025 ACLS update.

• Powered Drill is expected to account for 42.0% of technology demand in 2026, driven by faster tibial insertion and higher success rates in adult cardiac arrest scenarios.
• Hospital procurement teams are expected to favor powered drill systems if training costs remain manageable and device compatibility with standard infusion lines is confirmed.

What supports demand for distal and proximal tibia within the route of administration category?

Route of administration selection depends on anatomical accessibility, patient age, and clinical urgency. Tibial sites offer predictable landmarks that reduce insertion error during high-stress presentations. The European Resuscitation Council confirmed proximal tibia as the preferred adult IO site in its 2025 guidelines.

• Distal And Proximal Tibia is projected to hold 44.0% of route of administration demand in 2026, supported by clinical consensus on tibial access reliability.
• Emergency physicians are likely to prefer tibial routes if manufacturers provide site-specific needle lengths and insertion guidance.

How do hospitals influence purchasing within the end-user category?

Hospital emergency departments generate the highest-volume procurement for intraosseous devices due to trauma caseloads and cardiac arrest protocols.

• Hospitals are anticipated to represent 72.0% of end-user demand in 2026, attributable to equipment upgrades and protocol-driven purchasing.
• Ambulatory surgical centers and cardiology clinics are smaller segments where IO procurement follows procedural needs.

How do patient type and application categories shape intraosseous device demand?

Patient demographics determine needle gauge, insertion site, and device selection.

• Adult Patients is expected to represent 64.0% of patient type demand in 2026 because cardiac arrest and major trauma skew toward adult populations.
• Emergency Medicine is forecast to hold 58.0% of application demand in 2026.
• Military and disaster medicine remains a parallel channel where impact driven and manual IO devices retain relevance.

What are the drivers, restraints, and opportunities in the intraosseous devices?

Near-term procurement is shaped by clinical protocol updates, operator training requirements, and emergency department equipment modernization.

• Driver: Clinical guideline endorsements for intraosseous access are expected to push hospitals toward powered drill procurement tied to emergency protocol upgrades.
• Restraint: Adoption is likely to slow due to clinician training gaps, device cost sensitivity in price-constrained health systems, and limited IO insertion reimbursement clarity.
• Opportunity: Military and tactical medicine procurement cycles are expected to open supplier access if field-tested IO devices demonstrate reliability in austere conditions.

Clinical guideline updates from the American Heart Association and European Resuscitation Council are expected to increase purchasing among hospitals managing vascular access contracts. Teleflex reported in its 2025 annual filing that its EZ-IO powered drill platform maintained clinical leadership across emergency medicine accounts, supporting procurement confidence for buyers replacing manual IO kits.

Training gaps are expected to limit broad adoption if emergency physicians and paramedics receive insufficient IO insertion practice during certification. WHO reported in 2025 that emergency care systems in low and middle-income countries served fewer than 50% of populations needing acute intervention. That gap makes training critical before health systems expand IO procurement beyond tertiary hospitals.

Military procurement creates a practical route around the restraint by connecting field-tested evidence to defense medical budgets. The United States Department of Defense confirmed IO access as a standard tactical combat casualty care intervention in its 2025 guidelines, supporting demand for impact driven and powered IO devices in defense contracts.

Which country CAGRs are profiled in the intraosseous devices?

India 5.8%, China 5.4%, UK 3.7%, USA 1.8%, Germany 1.6% through 2036

Country	CAGR (2026 to 2036)
India	5.8%
China	5.4%
UK	3.7%
USA	1.8%
Germany	1.6%

Source: FMI's proprietary forecasting model and primary research. 5 of the countries covered in the full report are shown here as a representative subset.

How do country-level CAGRs compare in the Intraosseous Devices Market?

Intraosseous device growth turns on emergency-care formalization, EMS protocol adoption, and how quickly each health system moves from manual IO kits to powered platforms. India leads the profiled set while Germany grows more slowly; the countries shown are a representative subset, not a global ranking.

• The Intraosseous Devices Market in India is projected to grow at a 5.8% CAGR through 2036; for intraosseous devices, tertiary-care build-out and the formalization of emergency medicine are widening the base of hospitals that stock powered IO devices.
• The Intraosseous Devices Market in China is projected to grow at a 5. Training coverage for IO insertion outside metro trauma centers still limits volume. Suppliers win by pairing tiered pricing with paramedic and physician training that reaches district hospitals.
• The Intraosseous Devices Market in the United Kingdom is projected to grow at a 3.7% CAGR through 2036; for intraosseous devices, resuscitation-council protocols and NHS trust standardization route IO purchasing through structured emergency-equipment frameworks.
• The Intraosseous Devices Market in the United States is projected to grow at a 1. Framework listing and resuscitation-evidence requirements gate access. Suppliers need framework positions and responsive field service to turn trust wins into installed base.
• The Intraosseous Devices Market in Germany is projected to grow at a 1.6% CAGR through 2036; for intraosseous devices, specification-led hospital procurement and resuscitation-standard compliance shape which IO platforms clear evaluation.

Country-wise Analysis

• Indian providers buy intraosseous devices across expanding private hospital chains and cost-sensitive public tenders. Specification-led tenders and budget discipline lengthen the sales cycle. Suppliers need documented performance, service agreements, and compliance depth to win.
• Chinese hospitals procure intraosseous devices through centralized purchasing programs that reward registered, competitively priced products. Demand draws on clinical guideline endorsements for intraosseous access. In China, demand is predicted to advance at a 5.4% CAGR through 2036, supported by tertiary hospital expansion and county-level facility upgrades. Training coverage for IO insertion outside metro trauma centers still limits volume. Centralized-tender pricing squeezes margins even as emergency caseloads climb. Suppliers need provincial registration and distributor reach to convert protocol-driven demand.
• UK providers procure intraosseous devices through NHS frameworks and structured tender cycles. The Intraosseous Devices Market in the United Kingdom is projected to record a 3.7% CAGR during the assessment period, supported by NHS procurement frameworks and structured tender demand. Centralized-tender pricing squeezes margins even as emergency caseloads climb. Suppliers need provincial registration and distributor reach to convert protocol-driven demand.
• US providers procure intraosseous devices through GPO contracts against a large installed base on replacement cycles. Sales in the United States are forecast to expand at a 1.8% CAGR by 2036, supported by replacement cycles across a large installed base and GPO contracting. Framework listing and resuscitation-evidence requirements gate access. GPO cycles and clinical-evidence expectations control access to hospital volume. Suppliers protect renewals with GPO contracts, guideline citations, and dependable device service.
• German hospitals procure intraosseous devices through engineering-led, specification-driven tenders. The market outlook in Germany is anticipated to advance at a 1.6% CAGR over the assessment period, supported by structured hospital procurement and a large installed equipment base. GPO cycles and clinical-evidence expectations control access to hospital volume. Suppliers protect renewals with GPO contracts, guideline citations, and dependable device service.

Who are the notable companies in the intraosseous devices?

Teleflex Incorporated, Becton, Dickinson and Company (BD), Cook Medical Inc., Cardinal Health, Inc., Pyng Medical Corp., PerSys Medical, Argon Medical Devices, Inc., and SAM Medical are the notable companies shaping this market.

The field concentrates around vascular-access and critical-care companies that link resuscitation-guideline presence to hospital and EMS distribution. Emergency and tactical IO device specialists emphasize Tactical IO devices and Military and EMS IO devices, while regional and niche io device suppliers serve regional demand through Specialty vascular access. Global vascular access and critical care companies compete across Powered drill IO systems, Vascular access and infusion and Critical care vascular access throughout established accounts. A workable entry is a tactical or EMS IO niche, or a regional service model for a specific care setting. Growth then depends on regulatory clearance, insertion training, and dependable field service across each launch market. Breadth pays off through clinical teams that keep powered IO platforms guideline-referenced and serviceable in the field.

• Teleflex Incorporated and Becton, Dickinson and Company (BD) combine Powered drill IO systems and Vascular access and infusion across multiple national markets. Cook Medical Inc. adds Critical care vascular access through established account relationships. Their edge comes from guideline-referenced IO platforms and dependable field service.
• Pyng Medical Corp., PerSys Medical and Aero Healthcare follow focused routes across Tactical IO devices, Military and EMS IO devices and Emergency medical devices. Their commercial edge comes from field-proven tactical devices and insertion training rather than one standardized kit.
• Argon Medical Devices, Inc., BIOPSYBELL S.R.L. and Medax SRL Unipersonale provide regional coverage through Specialty vascular access. These firms compete on a narrow tactical and specialty-access focus, though geographic reach trails the global platforms.

Competitive Benchmarking: Intraosseous Devices Market

Company	Portfolio Relevance	IO Device Focus	Account Access	Service Reach
Teleflex Incorporated	High	Powered drill IO systems	Strong	Global
Becton, Dickinson and Company (BD)	High	Vascular access and infusion	Strong	Global
Cook Medical Inc.	Medium	Critical care vascular access	Strong	Global
Cardinal Health, Inc.	Medium	Medical device distribution	Strong	Global
Pyng Medical Corp.	High	Tactical IO devices	Moderate	Regional
PerSys Medical	High	Military and EMS IO devices	Moderate	Regional
Argon Medical Devices, Inc.	Medium	Specialty vascular access	Moderate	Regional
SAM Medical	Medium	Emergency medical devices	Moderate	Regional

Source: Future Market Insights competitive analysis, 2026. Ratings reflect relative portfolio relevance, workflow or project fit, service capability, and geographic reach.

Key Developments in the Intraosseous Devices Market

In March 2025, Teleflex reported continued clinical adoption of its EZ-IO powered vascular access system across emergency departments in North America and Europe. The company confirmed that EZ-IO remained the standard powered IO device referenced in AHA and ERC resuscitation guidelines.

In February 2025, PerSys Medical confirmed deployment of its FAST1 sternal IO device across military medical units participating in multinational tactical exercises. The device was used in simulated mass casualty drills requiring rapid vascular access.

Key Players in the Intraosseous Devices Market

Global vascular access and critical care companies

• Teleflex Incorporated
• Becton, Dickinson and Company (BD)
• Cook Medical Inc.
• Cardinal Health, Inc.

Emergency and tactical IO device specialists

• Pyng Medical Corp.
• PerSys Medical
• Aero Healthcare
• SAM Medical

Regional and niche IO device suppliers

• Argon Medical Devices, Inc.
• BIOPSYBELL S.R.L.
• Medax SRL Unipersonale
• StarFish Medical

Intraosseous Devices Market: Report Scope

Coverage field	Report scope
Market breakdown	Technology, route of administration, end user, patient type, application, and region.
Quantitative Units	Revenue in USD million, 2026 base-year value of USD 523.0 million, 2036 forecast value of USD 919.0 million, and 5.8% CAGR.
Market Definition	Intraosseous devices include powered drill, manual, automatic, and impact driven systems used for emergency vascular access through bone marrow when peripheral intravenous access is unavailable in trauma, cardiac arrest, and critical care settings.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and the Middle East and Africa.
Countries Covered	United States, China, India, Germany, United Kingdom, Japan, and Italy.
Key Companies Profiled	Teleflex Incorporated, Becton, Dickinson and Company (BD), Cook Medical Inc., Cardinal Health, Inc., Pyng Medical Corp., PerSys Medical, Argon Medical Devices, Inc., SAM Medical.
Forecast Period	2026 to 2036.
Approach	FMI used primary interviews, source validation, company authentication, and proprietary demand modeling to estimate market size, segment shares, country CAGRs.

Source: Future Market Insights, analysis driven by proprietary forecasting models and primary research

Intraosseous Devices Market: Research Methodology

Method	Approach
Primary Research	FMI interviewed emergency medicine device suppliers, hospital procurement managers, EMS agency logistics officers, and military medical supply chain leads. Inputs tested adoption triggers, technology preferences, training requirements, and replacement cycle patterns across patient types and countries.
Desk Research	Desk research used clinical guideline publications, regulator updates, defense medical procurement records, company filings, and official product pages. Evidence was restricted to public sources supporting emergency vascular access or company capability claims.
Market Sizing and Forecasting	The forecast model linked 2026 revenue anchors to emergency department caseloads, military procurement budgets, clinical guideline adoption, and country-specific healthcare investment. Segment shares were cross-checked against technology, route of administration, end-user procurement, and patient demographics.
Data Validation	Data validation reconciled every external statistic against its source title, date, and reported figure. Forecast values were checked against the ten-year CAGR formula and reviewed for section-level consistency.

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research

Market Segmentation Analysis

Intraosseous Devices Market Segmented by Technology:

• Powered Drill
  • Drill Assisted IO Devices
    • High Precision Placement
    • Advanced Trauma Care
  • Reusable Powered Systems
    • High Speed Insertion
    • Hospital Emergency Departments
• Manual
  • Hand Operated IO Devices
    • Emergency Vascular Access
    • Low Resource Healthcare Settings
  • Spring Loaded Manual Systems
    • Rapid Needle Insertion
    • Pre Hospital Emergency Care
• Automatic
  • Battery Powered IO Systems
    • Fast Needle Placement
    • Critical Care Applications
  • Electronic Guided Devices
    • Controlled Penetration Depth
    • Emergency Room Procedures
• Impact Driven
  • Impact Activated Devices
    • Rapid Trauma Response
    • Military Medical Applications
  • Single Use Impact Systems
    • Field Emergency Access
    • Disaster Response Operations

Intraosseous Devices Market Segmented by Route Of Administration:

• Distal And Proximal Tibia
  • Proximal Tibia Access
    • Pediatric Emergency Use
    • Easy Anatomical Landmarking
  • Distal Tibia Access
    • Alternative Vascular Route
    • Trauma Patient Applications
• Sternum
  • Adult Sternal Access
    • Rapid Circulatory Delivery
    • Cardiac Emergency Applications
  • Pre Hospital Sternal IO
    • Trauma And Shock Management
    • Military Emergency Care
• Distal Femur
  • Pediatric Distal Femur Access
    • Rapid Fluid Administration
    • Critical Care Use
  • Alternative Femoral Access
    • Emergency Drug Delivery
    • Severe Trauma Cases
• Calcaneus
  • Heel Bone Access Systems
    • Neonatal Emergency Care
    • Pediatric Resuscitation
  • Low Volume Emergency Access
    • Alternative IO Route
    • Critical Pediatric Situations
• Head Of Humerus
  • Proximal Humerus Access
    • High Flow Infusion Rates
    • Adult Emergency Medicine
  • Upper Extremity IO Systems
    • Rapid Medication Delivery
    • Advanced Trauma Support

Intraosseous Devices Market Segmented by End User:

• Hospitals
  • Emergency Departments
    • Critical Trauma Management
    • Rapid Resuscitation Procedures
  • Intensive Care Units
    • Advanced Vascular Access
    • Cardiac Emergency Support
• Ambulatory Surgical Centers
  • Outpatient Surgical Facilities
    • Short Duration Emergency Care
    • Rapid Patient Stabilization
  • Day Care Trauma Centers
    • Minimally Invasive Procedures
    • Emergency Preparedness
• Cardiology Clinics
  • Cardiac Emergency Clinics
    • Acute Cardiac Care
    • Rapid Medication Administration
  • Specialized Cardiovascular Centers
    • Critical Patient Monitoring
    • Emergency Access Support

Intraosseous Devices Market Segmented by Patient Type:

• Adult Patients
  • Adult Emergency Care
    • Cardiac Arrest Management
    • Trauma Resuscitation
  • Critical Care Patients
    • Rapid Drug Administration
    • Intensive Care Applications
• Pediatric Patients
  • Infant Emergency Access
    • Rapid Fluid Delivery
    • Neonatal Resuscitation
  • Child Trauma Care
    • Pediatric Emergency Procedures
    • Difficult Venous Access Cases
• Geriatric Patients
  • Elderly Critical Care
    • Emergency Medication Delivery
    • Age Related Vascular Challenges
  • Long Term Care Emergencies
    • Rapid Access In Acute Situations
    • Hospital Emergency Support

Intraosseous Devices Market Segmented by Application:

• Emergency Medicine
  • Trauma Care Applications
    • Rapid Vascular Access
    • Emergency Drug Delivery
  • Cardiac Arrest Management
    • Advanced Life Support
    • Critical Patient Stabilization
• Military And Disaster Medicine
  • Battlefield Medical Support
    • Pre Hospital Emergency Access
    • Combat Trauma Care
  • Disaster Response Operations
    • Mass Casualty Management
    • Rapid Patient Triage
• Critical Care And Surgery
  • Intensive Care Procedures
    • Continuous Fluid Administration
    • Critical Monitoring Support
  • Surgical Emergency Support
    • Perioperative Drug Delivery
    • Advanced Patient Management

Intraosseous Devices Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. American Heart Association. (2025). 2025 AHA Guidelines for CPR and Emergency Cardiovascular Care.
• 2. European Resuscitation Council. (2025). European Resuscitation Council Guidelines 2025: Adult Advanced Life Support.
• 3. World Health Organization. (2025). Emergency Care Systems: Status and Gaps in Low and Middle-Income Countries.
• 4. United States Food and Drug Administration. (2025). 510(k) Premarket Notification Database: Intraosseous Devices.
• 5. United States Department of Defense. (2025). Tactical Combat Casualty Care Guidelines, Fourth Edition.
• 6. Teleflex Incorporated. (2025). Annual Report and Form 10-K Filing.
• 7. Becton, Dickinson and Company. (2025). Vascular Access Product Portfolio Update.
• 9. National Health Commission of the People's Republic of China. (2025). Emergency Care Standardization Requirements for Tertiary Hospitals.
• 10. NHS England. (2025). Emergency Department Equipment Standards and Ambulance Trust Procurement Framework.

This bibliography is provided for reader reference and uses primary government sources plus standards-body sources. Clinical body and company sources are included.

This Report Answers

• What is the estimated 2026 value of the intraosseous devices?
• What market value is projected for intraosseous devices by 2036?
• What CAGR is forecast for intraosseous devices from 2026 to 2036?
• Which technology is expected to account for a notable 2026 share?
• Which countries are profiled for CAGR comparison?
• Which companies are notable in the competitive landscape?